High in-vivo stability in preclinical and first-in-human experiments with [ 18 F]AlF-RESCA-MIRC213: a 18 F-labeled nanobody as PET radiotracer for diagnosis of HER2-positive cancers.

Xue QinXiaoyi GuoTianyu LiuLiqiang LiNina ZhouXiaopan MaXiangxi MengJiayue LiuHua ZhuBing JiaZhi Yang

Published in: European journal of nuclear medicine and molecular imaging (2022)

F]AlF-RESCA-MIRC213 PET/CT is a safe procedure with favorable pharmacokinetics and dosimetry profile, and it is a promising new PET radiotracer for noninvasive diagnosis of HER2-positive cancers.

Keyphrases

pet ct
pet imaging
positron emission tomography
endothelial cells
computed tomography
cell therapy
induced pluripotent stem cells
bone marrow
mesenchymal stem cells
young adults
childhood cancer